Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma
Article in PLOS ONE (January 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in PLOS ONE (January 2022)
Article in BMC Health Services Research (September 2021)
Article in Expert Review of Pharmacoeconomics & Outcomes Research (December 2020)